BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular
Cancer cells have unique metabolic and bioenergetic properties allowing them to thrive in nutrient poor environments and maximize cell growth and proliferation. Myriad inputs feed into the metabolism of cancer and cancer-associated cells as well as interactions within the tumor microenvironment. Understanding the flexibility of changes in the
BMC Pharmacology and Toxicology Transparent peer review BMC Research Notes Breast Cancer Research Cancer Metabolism Cancer Cell International Clinical Epigenetics Epigenetics Communications Fluids and Barriers of the CNS Genes Nutrition Genes and Environment Genome Medicine Hereditary Cancer in Clinical Practice Open peer review
Cancer Communications is no longer published by BMC. The journal is continuing in cooperation with Wiley as of 1 January 2020. The new journal website is
BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular
At BMC research is always in progress. We are committed to continual innovation to better support the needs of our communities ensuring the integrity of the research we publish and championing the benefits of open research. BMC is part of Springer Nature.
Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities ta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast
Maria manages a team of in-house editors on the BMC Series journals including the editors for BMC Cancer BMC Genomics and BMC Plant Biology. She joined the BMC Series in July 2018. Previously Maria was the Scientific Publications Manager for Cancer Research UK managing the British Journal of Cancer and developing the scientific publishing
Cancer Cell International Celebrating 20 years. 2021 marks the 20th year since Cancer Cell International published its very first articles.To mark this occasion we re looking back at the journal s milestone achievements and highlighting some of the best content from the past 20 years.
Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities ta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast
Cancer Cell International Celebrating 20 years. 2021 marks the 20th year since Cancer Cell International published its very first articles.To mark this occasion we re looking back at the journal s milestone achievements and highlighting some of the best content from the past 20 years.
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies with a specific emphasis on research that explores the biological mechanisms of action as well as their efficacy safety costs patterns of use
Molecular Cancer is a top rated Springer Nature journal. Prof. Christophe Nicot and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.
BMC Cancer is an open access peer-reviewed journal covering all aspects of cancer research including the pathophysiology of cancer prevention diagnosis and treatment.. has been in the process of posting for about 4 months and has experienced 3 revisions in the middle.
BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology genetics epidemiology and clinical trials.
BMC Cancer is an open access peer-reviewed journal that considers articles on all aspects of cancer research including the pathophysiology prevention diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular
Cancer cells have unique metabolic and bioenergetic properties allowing them to thrive in nutrient poor environments and maximize cell growth and proliferation. Myriad inputs feed into the metabolism of cancer and cancer-associated cells as well as interactions within the tumor microenvironment. Understanding the flexibility of changes in the
The Regional Cancer Center (RCC) of the Bicol Medical Center is a four-story ambulatory care facility that offers state-of-the-art treatment and multidisciplinary management of cancer patients from screening diagnosis treatment and management and palliative care. Regional Cancer Center Bldg. BMC Rd. Concepcion Pequeña Naga City
2020-6-24 · Colorectal cancer (CRC) continues to be a major public health problem both in the United States and worldwide it is the third most common cancer in the United States with approximately 150 000 new cases per year 1 2 . Metastatic disease currently remains predominantly incurable and treatment is primarily for palliation of symptoms and disease control.
BMC Cancer does not consider case reports. For pre-clinical and experimental research we only consider studies that provide results validated in at least 3 relevant cell lines preferably validated in at least one animal model. Please note that manuscripts consisting solely of bioinformatics computational analysis or predictions of public
Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities ta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast
Cancer is a group of diseases driven by inherently nanostructural problems. As such there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or indeed both
Maria manages a team of in-house editors on the BMC Series journals including the editors for BMC Cancer BMC Genomics and BMC Plant Biology. She joined the BMC Series in July 2018. Previously Maria was the Scientific Publications Manager for Cancer Research UK managing the British Journal of Cancer and developing the scientific publishing
2021-4-13 · Cancer Metabolism BMC Biology and Cancer Metabolism. Cross journal collection In the Light of Evolution . View all collections. On Biology . MinION Democratising biodiversity research by misusing a portable long-read sequencer for short-read barcoding. 04 December 2019.
Molecular Cancer is a top rated Springer Nature journal. Prof. Christophe Nicot and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.
Cancer Cell International Celebrating 20 years. 2021 marks the 20th year since Cancer Cell International published its very first articles.To mark this occasion we re looking back at the journal s milestone achievements and highlighting some of the best content from the past 20 years.
2021-7-4 · BMC CANCER BMC CANCER 1471-2407 2021/JCR 4.430/Q3 ENGLAND Irregular 2001 889 OA Yes bmccancer.biomedcentral
Journal of Experimental Clinical Cancer Research is a top rated Springer Nature journal. Prof. Mauro Castelli and the editorial team performed in the top percentile of journals based on data collected from the Journal Author Satisfaction Survey. We are recognising extraordinary editors for their commitment and passion to their journals.
BMC Medicine is the flagship medical journal of the BMC series. An open access transparent peer-reviewed general medical journal BMC Medicine publishes outstanding and influential research in all areas of clinical practice translational medicine medical and health advances public health global health policy and general topics of interest to the biomedical and sociomedical professional
Cancer Communications is no longer published by BMC. The journal is continuing in cooperation with Wiley as of 1 January 2020. The new journal website is
BMC Medicine and BMC Cancer are welcoming submissions to a new joint collection on cancer targeted therapies. We are seeking manuscripts on all aspects of molecular targeted therapies including novel therapies treatment resistance combination therapies and biomarker discovery.
1 day ago · Cutaneous squamous cell carcinoma (cSCC) often follows actinic keratosis (AK) and is the second most common skin cancer worldwide. To reduce metastasis risk it is important to diagnose and treat cSCC early. This study aimed to identify hub genes associated with cSCC and AK. This study used three datasets GSE45216 GSE98774 and GSE108008. We combined samples from the GSE45216
1 day ago · Cutaneous squamous cell carcinoma (cSCC) often follows actinic keratosis (AK) and is the second most common skin cancer worldwide. To reduce metastasis risk it is important to diagnose and treat cSCC early. This study aimed to identify hub genes associated with cSCC and AK. This study used three datasets GSE45216 GSE98774 and GSE108008. We combined samples from the GSE45216
2021-4-13 · Cancer Metabolism BMC Biology and Cancer Metabolism. Cross journal collection In the Light of Evolution . View all collections. On Biology . MinION Democratising biodiversity research by misusing a portable long-read sequencer for short-read barcoding. 04 December 2019.
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies with a specific emphasis on research that explores the biological mechanisms of action as well as their efficacy safety costs patterns of use
BMC Pharmacology and Toxicology Transparent peer review BMC Research Notes Breast Cancer Research Cancer Metabolism Cancer Cell International Clinical Epigenetics Epigenetics Communications Fluids and Barriers of the CNS Genes Nutrition Genes and Environment Genome Medicine Hereditary Cancer in Clinical Practice Open peer review
Cancer Metabolism is excited to present the following article highlights that identify novel biomarkers and metabolic profiles of different breast cancer subtypes.Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities ta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast
BMC Pharmacology and Toxicology Transparent peer review BMC Research Notes Breast Cancer Research Cancer Metabolism Cancer Cell International Clinical Epigenetics Epigenetics Communications Fluids and Barriers of the CNS Genes Nutrition Genes and Environment Genome Medicine Hereditary Cancer in Clinical Practice Open peer review
Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology radiation physics radiation technology and clinical oncology. The field of radiation oncology covers the integration of radiation therapy into multimodal treatment
BMC Medicine is the flagship medical journal of the BMC series. An open access transparent peer-reviewed general medical journal BMC Medicine publishes outstanding and influential research in all areas of clinical practice translational medicine medical and health advances public health global health policy and general topics of interest to the biomedical and sociomedical professional
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
